Email Facebook Twitter

UPDATE: #COPL set timeline for Q2/Q3 Nigeria drilling programme
RESULTS: IFA led wealth managers AFH Financial results show strong growth

Glaxosmithkline Share News (GSK)

Stock Market news at - RSS News Feeds

Share News for Glaxosmithkline (GSK)

Share Price: 1,581.00Bid: 1,582.00Ask: 1,582.80Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.80Spread as %: 0.05%Open: 1,567.00High: 1,592.40Low: 1,567.00Yesterday’s Close: 1,581.00

UPDATE 2-FTSE 100 squeezes out gains; ConvaTec drags midcaps

* FTSE 100 up 0.1 pct* FTSE 250 down 0.4 pct* Micro Focus top blue-chip gainer after results* AstraZeneca rises on Q4 sales beat, strong forecast* Con
[14 Feb '19 10:30]

Irish drug trial technology firm Teckro wins $25 mln injection

* Investors including fund managed by Bill Maris, Founders Fund* Teckro sees IPO as longer-term option* Aims to digitize clinical drug trials, lower d
[14 Feb '19 08:00]

Drugmakers say UK could lose out on EU anti-counterfeit drugs push

Feb 8 (Reuters) - Drugmakers warned on Friday that if Britain leaves the European Union without a deal next month Britons could miss out on an EU-wide
[8 Feb '19 00:01]

LIVE MARKETS-Investing in uninvestible Britain

* European stocks tumble as poor earnings weigh * TUI sinks 18 pct after cutting profit outlook * Publicis and GEA Group down 14 pct after res
[7 Feb '19 10:36]

UPDATE 2-Publicis plunges after shock fall in revenue

* Almost 2 bln euros wiped off firm's market value* Publicis Q4 revenues well below forecasts* Shares of rivals also dragged lower (Adds analysts, det
[7 Feb '19 09:33]

Norway wealth fund flexes its muscles on executive pay, CEOs holding role of chairman

* Largest SWFs:, Feb 7 (Reuters) - Norway's sovereign wealth fund, the world's largest, voted against one or more resolut
[7 Feb '19 09:08]

UPDATE 1-Publicis lifts full-year profits despite sluggish sales

* Q4 organic growth far below consensus* Operating margin and EPS above targets* CEO doubles down on strategy to move toward consulting (Adds details)
[6 Feb '19 17:20]

UPDATE 3-Profits at Britain's GSK boosted by sales of shingles vaccine

* Sees 2019 FY profit declining between 5 and 9 percent* Jefferies says 2019 EPS target should be well received* Advair sales fell 20 pct, but top est
[6 Feb '19 12:26]

Share Price, Share Chat, Stock Market news at
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.